Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease (Q48655836)
scientific article published on July 25, 1997
Language:
(P31) (Q13442814)
(P50) (Q56850450)
(P304) 145-158
(P407) (Q1860)
(P433) 2
(P478) 763
(P577) Tuesday, July 1, 1997
Friday, July 25, 1997
(P921) (Q11081)
(Q7208)
(Q79460)
(P953) https://api.elsevier.com/content/article/PII:S0006899397003843?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0006899397003843?httpAccept=text/plain
(P1104) 14
(P1433) (Q4955782)
(P1476) "Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease" (language: en)
(P2093) F. Grynspan
W. R. Griffin
A. Cataldo
S. Katayama
(P2860) (Q53191493)
(Q48930800)
(Q46598715)
(Q37721348)
(Q28242505)
(Q48218777)
(Q48120501)
(Q29622896)
(Q68437243)
(Q48171231)
(Q46353110)
(Q70680939)
(Q70658101)
(Q49019923)
(Q68145766)
(Q37767409)
(Q70138375)
(Q42053214)
(Q48852532)
(Q48571996)
(Q48436144)
(Q33720044)
(Q70770912)
(Q29617284)
(Q48284299)
(Q54381219)
(Q48341418)
(Q34557016)
(Q44325145)
(Q48344642)
(Q41893869)
(Q38582618)
(Q67274939)
(Q48690677)
(Q48640495)
(Q54242639)
(Q54344500)
(Q53211402)
(Q53188131)
(Q70197223)
(Q37580789)
(Q53207036)
(Q25938983)
(Q53179342)
(Q53210401)
(Q53296439)
(Q35373888)
(Q71342378)
(Q54166777)
(Q48330550)
(Q37420048)
(Q71493339)
(Q38208892)
(Q41676396)
(Q29614948)
(Q53303482)
(Q41621329)
(Q53303901)
(Q38327364)
(Q48737321)
(Q48350653)
(Q37542016)
(Q42000714)
(Q34620363)
(Q46501561)
(Q33580107)
(Q70891225)
(Q68159073)
(Q54631999)
(Q36188775)
(Q71845647)
(Q46125035)
(Q71894597)
(Q71071828)
(Q48669811)
(Q72368139)
(Q36270723)
(Q41269928)
(Q37923669)
(Q48498366)
(Q48233856)
(Q48296613)
(Q52209534)
(Q33586330)
(Q33582860)
(Q71814389)
(Q40586932)
(Q48307083)
(Q33937669)
(Q38216634)
(Q36199527)
(Q35885900)
other details
description scientific article published on July 25, 1997

External Links